IBSA celebrates 40 years of history: “Drugs in the best form” – a success story that combines innovation with a focus on people
In 1985, IBSA (Institut Biochimique SA) was a small company in Lugano on the brink of bankruptcy. Today, 40 years later, the company celebrates the anniversary of its acquisition by its current CEO and President, Arturo Licenziati, who has led the business with a key philosophy: “Drugs in the best form”.
The year 2025 marks an important year for the IBSA Group (Institut Biochimique SA), which celebrates a double anniversary: 40 years of leadership by its CEO and President Arturo Licenziati, and 80 years sincethecreation of theIBSA name. These milestones coincide with another significant event: the 90th birthday of President Licenziati, who today – April 3, 2025 – celebrates this major occasion.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250327550789/en/
To mark the company’s 40th anniversary, IBSA has decided to grant all employees worldwide a day off on August 19, the date when Arturo Licenziati first stepped into IBSA.
“This is just a symbolic gesture to express my gratitude for the commitment, dedication and passion of our People, who are the driving force behind our growth. A growth that is not just about business, but also – and above all – about the ability to implement development and work models that place People at the centre of our philosophy and our activities”, said Licenziati.
Indeed, it was on August 19, 1985, that Licenziati took over the management of the Ticino-based company, founded in Lugano in 1945, redefining its vision and strategy. At that time, IBSA had just 40 employees and a turnover of 5 million Swiss francs. However, by the end of the 1980s – in just 5 years – the company had radically transformed, tripling its revenue.
The history of IBSA is the story of a company that evolved from a small pharmaceutical laboratory in the Swiss Canton Ticino into a multinational corporation. What many people saw as an impossible mission, President Licenziati embraced as a challenge to be won, with the aim of forging a new path, focused on innovation and the ability to respond to people’s actual needs.
“Small companies can only grow if they can adapt quickly to sectors that large pharmaceutical companies often overlook”, added Licenziati. “Over the years, we have transformed an idea –producing “drugs in the best form” – into a concrete and successful project, focusing on targeted research that meets the everyday needs of doctors and patients. We have always been a forward-looking company, ready to go beyond and willing to explore new, uncharted paths”.
Since the 1990s, IBSA has embarked on a global expansion, first in Europe and then worldwide. Today the company has 20 subsidiaries across Europe, China and the United States, and distributes its products in over 90 countries across 5 continents, with more than 2,300 employees between headquarters, subsidiaries and production sites.
About IBSA |
IBSA (Institut Biochimique SA) is a Swiss multinational pharmaceutical company with 20 subsidiaries in Europe, China and the United States. Its products are distributed in over 90 countries and its research and development activity focuses on 10 therapeutic areas. In 2025, IBSA celebrates the 40th anniversary of its acquisition by current President and CEO Arturo Licenziati, who transformed the company into a multinational that employs over 2,300 people worldwide. IBSA’s growth and development can be attributed to the ability to innovate by perfecting already known molecules, as well as to the desire to look to the future in a responsible and transparent way, thanks to the dedication and dynamism of its people. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20250327550789/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Western Union Offers Zero-Fee International Money Transfers to Myanmar4.4.2025 03:00:00 CEST | Press release
Available to consumers around the world sending money to their loved ones in Myanmar via WesternUnion.com and the Western Union app In response to the devastating earthquake that recently struck Myanmar, Western Union today announced that it is offering consumers around the world zero-fee international money transfers1 to the country. Effective immediately until midnight, 00:00 Myanmar Standard Time on 10 April 2025, individuals can send funds to Myanmar via WesternUnion.com or the Western Union mobile app, ensuring families can provide crucial support to their loved ones during this time of urgent need. Western Union remains committed to providing support during times of crisis, offering zero-fee transfers whenever possible to help communities in need. Money transfers sent to Myanmar will be: Available for payout into bank accounts. Available for payout into select mobile wallets Available for payouts incash at Agent locations2 “Our thoughts are with the people of Myanmar during this
Clean Tech Leader Aymium Defeats Stora Enso at European Patent Office Boards of Appeal4.4.2025 00:07:00 CEST | Press release
Ruling Maintains Aymium's Patent and Leading Position in Renewable Batteries and Anodes Cleantech leader Aymium defeated a challenge by Stora Enso to one of Aymium's patents (European Patent EP2697185) that provides exclusive rights to produce, sell and use bio-based materials for renewable battery applications. In its written opinion, the Boards of Appeal of the European Patent Office found Stora Enso's arguments brought before the board “not convincing” and agreed that a clarifying amendment to the claims did not extend the scope of protection of the patent. The ruling further affirms Aymium's position as the global leader in biocarbon materials for battery applications. Beyond the present ruling, Aymium owns a portfolio of more than 600 patents relating to biocarbon materials, compositions and manufacturing methods, including many specifically relevant to battery materials, and is the dominant global innovator regarding biocarbon materials. The ruling, combined with Aymium's massive
Esri Helps Bring Up-to-Date Road Closure Information To Consumer Mapping Apps3.4.2025 23:24:00 CEST | Press release
ArcGIS Users Can Provide Road Closure Data to Apple Maps and TomTom to Help Improve Travel for Motorists Esri, the global leader in GIS technology and location intelligence, has enhanced its popular Community Maps Program to make sharing of road closures much easier with the Road Closures solution. This new solution in Esri's ArcGIS, the leading and most comprehensive geospatial platform, bridges the gap between government agencies managing timely road updates and the public, who rely on mapping apps for real-time navigation. Thousands of Esri's ArcGIS software users — including state and local governments and national mapping agencies — create and share authoritative, accurate road data through the Esri Community Maps Program, and now they can share live road closure data as well. Esri ArcGIS users can now easily share road closure updates directly with consumer mapping providers including Apple Maps and TomTom, so they can update their maps with this important information. "Through t
smartTrade Announces Strategic Investment from TA alongside CEO and Management3.4.2025 18:37:00 CEST | Press release
smartTrade Technologies (“smartTrade”), a leading global provider of multi-asset electronic trading and payments platforms, today announced a strategic investment from TA Associates (“TA”), a leading global private equity firm. David Vincent, CEO and Co-Founder of smartTrade, and the broader management team, would invest alongside TA at closing, reinforcing their shared commitment to the company’s future. Headquartered in Aix-en-Provence, France, with subsidiaries in London, Paris, Geneva, New York, Toronto, Tokyo and Singapore, smartTrade empowers customers to grow their electronic trading and payments business through secure, cost-efficient and technologically advanced end-to-end SaaS solutions. TA’s investment would support continued product innovation, geographic expansion and scalable growth, with a particular emphasis on AI-driven solutions and deployment flexibility. Upon completion of the transaction, Hg, a leading investor in European and transatlantic software and services bu
Barilla Ranks as the First Food Company in the World for Reputation in the 2025 Global RepTrak® 1003.4.2025 17:59:00 CEST | Press release
Barilla Group is proud to announce its rise in the Global RepTrak® 100 rankings, emerging as the leading company in the food sector two years running. The company has secured the 25th position worldwide, moving up four spots compared to 2024, where it held the 29th position. This result, achieved thanks to the efforts of the Group’s people worldwide, reflects its continued focus on the quality of its products and services, inclusion, innovation, and willingness to bring people together through good food. With a presence in over 100 countries and 30 production sites (15 in Italy and 15 abroad), Barilla Group produces more than 2 million tons of products each year. Since 2010, it has reformulated nearly 500 products to improve their nutritional profile, reducing fats, saturated fats, salt, and sugar, or increasing fiber content. Aligned with its commitment to fostering inclusivity, in France the company has achieved a 100% score on the Professional Gender Equality Index1 this year, an in
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom